- Home
- CBFV vs AVR Comparison
CBFV vs AVR Comparison
Compare CBFV & AVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- AVR
- Stock Information
- Founded
- CBFV 1901
- AVR 1999
- Country
- CBFV United States
- AVR Australia
- Employees
- CBFV N/A
- AVR N/A
- Industry
- CBFV Major Banks
- AVR
- Sector
- CBFV Finance
- AVR
- Exchange
- CBFV Nasdaq
- AVR NYSE
- Market Cap
- CBFV 140.0M
- AVR 162.1M
- IPO Year
- CBFV N/A
- AVR 2024
- Fundamental
- Price
- CBFV $28.65
- AVR $3.17
- Analyst Decision
- CBFV Hold
- AVR Strong Buy
- Analyst Count
- CBFV 2
- AVR 4
- Target Price
- CBFV $26.00
- AVR $16.50
- AVG Volume (30 Days)
- CBFV 43.0K
- AVR 314.1K
- Earning Date
- CBFV 07-23-2025
- AVR 08-16-2025
- Dividend Yield
- CBFV 3.44%
- AVR N/A
- EPS Growth
- CBFV N/A
- AVR N/A
- EPS
- CBFV 1.92
- AVR N/A
- Revenue
- CBFV $49,545,000.00
- AVR $2,493,000.00
- Revenue This Year
- CBFV $5.97
- AVR $33.26
- Revenue Next Year
- CBFV $9.49
- AVR $194.42
- P/E Ratio
- CBFV $15.15
- AVR N/A
- Revenue Growth
- CBFV N/A
- AVR N/A
- 52 Week Low
- CBFV $22.16
- AVR $2.34
- 52 Week High
- CBFV $33.72
- AVR $8.79
- Technical
- Relative Strength Index (RSI)
- CBFV 57.50
- AVR N/A
- Support Level
- CBFV $28.78
- AVR N/A
- Resistance Level
- CBFV $29.43
- AVR N/A
- Average True Range (ATR)
- CBFV 0.50
- AVR 0.00
- MACD
- CBFV 0.17
- AVR 0.00
- Stochastic Oscillator
- CBFV 83.19
- AVR 0.00
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.